Close
Smartlab Europe
Inizio Ignite

Press Releases

Seqirus Announces New Facility Supporting Research & Development of Leading-Edge Influenza Vaccine Technology

Seqirus, a global leader in influenza prevention and a business of CSL Limited announced an investment in a new Research and Development (R&D) facility located in Waltham, Mass. The new facility will support the company’s growing R&D portfolio, with...

Thermo Fisher Scientific Partners with Medidata Acorn AI to Optimize Clinical Research Site Selection and Speed Patient Enrollment in Clinical Trials

Thermo Fisher Scientific Inc., the world leader in serving science, announced a multiyear partnership with Medidata Acorn AI, a Dassault Systèmes company leading the digital transformation of life sciences. Through this partnership, the PPD clinical research business of Thermo...

Piramal Pharma Solutions Strengthens UK Presence with the Expansion and Upgrade of its Grangemouth and Morpeth Facilities

Piramal Pharma Limited’s Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced the expansion of its Antibody-Drug Conjugate (ADC) capabilities at the Grangemouth facility in Scotland and the investment in new Active Pharmaceutical Ingredient (API) infrastructure...

DuPont invests in bioprocessing supply chain to enhance purchasing of its products for drug development

DuPont has launched a new online sales portal tailored to the needs of bioprocessing industry purchasers. The portal handles online sales transactions, with target lead times of < 1 week. DuPont’s bioprocessing solutions enable sophisticated purifications and separations for therapeutics...

Bruker Launches New timsTOF-based MALDI PharmaPulse Solution for Label-free HTS in Drug Discovery

Bruker Corporation announced the launch of its timsTOF MALDI PharmaPulse® (timsTOF MPP) system, a groundbreaking new high-end solution for unbiased, deep HTS and uHTS based on label-free mass spectrometry. The new timsTOF® MPP is now the flagship of Bruker´s MALDI...

T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants

T2 Biosystems, Inc, a leader in the rapid detection of sepsis-causing pathogens, announced that its T2SARS-CoV-2™ Panel detects Omicron COVID-19 subvariants BA.1, BA.2, and BA.3. According to the Centers for Disease Control and Prevention, the Omicron variant of the SARS-CoV-2...

Procaps Group Announces Capacity Expansion Plans in the United States with Construction of New Gummy Manufacturing Facility in Florida

Procaps Group, a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced a new capacity expansion plan in the United States and Colombia for its Funtrition business through a new gummy manufacturing facility and increased manufacturing capabilities to meet rising...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »